Adicet Bio (ACET) Net Income (2017 - 2026)
Adicet Bio (ACET) posted quarterly Net Income of -$20.2 million for Q1 2026, up 28.25% year-over-year from -$15.8 million in Q1 2025, and down 44108.7% quarter-over-quarter from $46000.0 in Q4 2025.
Adicet Bio (ACET) Net Income (2017 - 2026) Analysis & Trends
Adicet Bio's Net Income history runs 10 years deep, the most recent figure standing at -$20.2 million for Q1 2026.
- In Q1 2026, Net Income rose 28.25% year-over-year to -$20.2 million; the TTM figure through Mar 2026 stood at -$47.1 million (down 254.8% YoY), while the FY2025 annual figure was $86000.0, up 437.5% from the prior year.
- Net Income for Q1 2026 stood at -$20.2 million, down from $46000.0 in the prior quarter.
- The five-year high for Net Income was $88.4 million in Q4 2024, with the low at -$49.9 million in Q3 2023.
- The 5-year median for Net Income is -$22.5 million (2022), against an average of -$13.3 million.
- Peak annual rise in Net Income reached 121.66% in 2022, while the deepest fall reached 199863.64% in 2022.
- Adicet Bio's Net Income stood at -$29.9 million in 2022, then sank by 66.98% to -$49.9 million in 2023, then soared by 277.23% to $88.4 million in 2024, then sank by 99.95% to $46000.0 in 2025, then sank by 44108.7% to -$20.2 million in 2026.
- Business Quant data shows ACET's Net Income at -$20.2 million in Q1 2026, $46000.0 in Q4 2025, and -$26.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 81.49 Mn |
| 10 | Adicet Bio | 98.59 Mn | -19.60 Mn | - | -21.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.36 Mn |
| Mar 31, 2026 | -20.24 Mn |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | -26.86 Mn |
| Jun 30, 2025 | -32,000.00 |
| Mar 31, 2025 | -28.21 Mn |
| Dec 31, 2024 | 88.41 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -29.90 Mn |
| Sep 30, 2023 | -49.89 Mn |
| Jun 30, 2023 | -32.40 Mn |
| Mar 31, 2023 | -30.88 Mn |
| Dec 31, 2022 | -29.88 Mn |
| Sep 30, 2022 | -22.00 Mn |
| Jun 30, 2022 | -22.54 Mn |
| Mar 31, 2022 | 4.62 Mn |
| Dec 31, 2021 | -15.81 Mn |
| Sep 30, 2021 | -11,000.00 |
| Jun 30, 2021 | 75,000.00 |
| Mar 31, 2021 | -21.32 Mn |